JW Pharmaceutical Corporation
Symbole: 001060.KS
KSC
30750
KRWPrix du marché aujourd'hui
18.7613
Ratio P/E
0.2072
Ratio PEG
707.11B
Cap MRK
- 0.01%
Rendement DIV
JW Pharmaceutical Corporation (001060-KS) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 369240.03 | 92838 | 149678.7 | 65666.1 | |||||||||||||||||
balance-sheet.row.short-term-investments | 280726.91 | 76929.2 | 115780.8 | 32299.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 689190.07 | 173629.3 | 162146.2 | 192840 | |||||||||||||||||
balance-sheet.row.inventory | 456503.25 | 106091.4 | 111668.4 | 102527.6 | |||||||||||||||||
balance-sheet.row.other-current-assets | 15865.72 | 5532.7 | 1963.7 | 5417.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1530799.07 | 378091.4 | 425457.1 | 366451.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 624681 | 155723.7 | 123048.1 | 118392.3 | |||||||||||||||||
balance-sheet.row.goodwill | 11794.82 | 1404.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 96046.76 | 28952 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 104378.13 | 30356.4 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 74489.66 | 52498.2 | -81554 | 69814.7 | |||||||||||||||||
balance-sheet.row.tax-assets | 89655.86 | 20623.3 | 21811.3 | 20802.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 207068.03 | 7745.9 | 122944.1 | 36119.4 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 1100272.68 | 266947.4 | 202515.7 | 266601.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.account-payables | 262951.71 | 73847.2 | 82907.9 | 51642.9 | |||||||||||||||||
balance-sheet.row.short-term-debt | 667547.61 | 117404.6 | 207693 | 123074.6 | |||||||||||||||||
balance-sheet.row.tax-payables | 52523.03 | 11113.5 | 13983.9 | 29008.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 173876.69 | 30000 | 1849.3 | 122070.1 | |||||||||||||||||
Deferred Revenue Non Current | 1431.95 | 1325.4 | 0 | -13199.8 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 5294.44 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 298716.84 | 89585.4 | 82814.9 | 35045.6 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 309778.22 | 92671.2 | 22082.6 | 161836 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 107834.96 | 22875.8 | 3102.6 | 2600.9 | |||||||||||||||||
balance-sheet.row.total-liab | 1624750.34 | 379598.3 | 402213.7 | 444513.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 14694.66 | 3173.6 | 3973 | 3352.6 | |||||||||||||||||
balance-sheet.row.common-stock | 229703.46 | 57925.9 | 55445.2 | 53849.8 | |||||||||||||||||
balance-sheet.row.retained-earnings | 370663.26 | 92612 | 89129.8 | 58594.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 82131.39 | 53896.2 | 51771.8 | 52070.7 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 323844.34 | 57832.7 | 40034.3 | 33327 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1021037.11 | 265440.5 | 240354.1 | 201194.8 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.minority-interest | -14715.71 | 0 | -14595.1 | -12655.2 | |||||||||||||||||
balance-sheet.row.total-equity | 1006321.4 | 265440.5 | 225759 | 188539.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2631071.75 | - | - | - | |||||||||||||||||
Total Investments | 355216.57 | 129427.3 | 34226.8 | 102114.3 | |||||||||||||||||
balance-sheet.row.total-debt | 887720.78 | 170280.4 | 209542.3 | 245144.7 | |||||||||||||||||
balance-sheet.row.net-debt | 799207.66 | 154371.6 | 175644.4 | 211778.2 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 37151.21 | 35096 | 29852.6 | -1441.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 22574.6 | 22444.6 | 16836.3 | 16111.7 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -20262.51 | -20262.5 | -6169.7 | -46055.8 | |||||||||||||||||
cash-flows.row.account-receivables | -3162.23 | -3162.2 | -4352.5 | -41296.6 | |||||||||||||||||
cash-flows.row.inventory | 8916.8 | 8916.8 | -11541.3 | -2655.1 | |||||||||||||||||
cash-flows.row.account-payables | -9535.56 | -9535.6 | 31652.3 | 3729.7 | |||||||||||||||||
cash-flows.row.other-working-capital | -16481.52 | -16481.5 | -21928.1 | -5833.7 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 47693.94 | 49879.1 | 16245.2 | 49509.5 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 87157.24 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.acquisitions-net | -14325.59 | -12034 | -40.9 | 385 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -61344 | -61344 | -73817.4 | -140023.5 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 69604.03 | 69604 | 47473.7 | 141101.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | -19152.8 | -17093.1 | 19817.9 | -11430.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -63780.27 | -63834.3 | -18919.2 | -22869.2 | |||||||||||||||||
cash-flows.row.debt-repayment | -216351.12 | -28189.8 | -177004.4 | -98658.1 | |||||||||||||||||
cash-flows.row.common-stock-issued | 7880.94 | -3873 | 10000 | 398.5 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -260.87 | -260.9 | -281.6 | -412.3 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -8813.7 | -7352 | -7149.5 | |||||||||||||||||
cash-flows.row.other-financing-activites | 176299.39 | -54 | 137730.5 | 133023 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -41245.33 | -41191.3 | -36907.5 | 27201.6 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -120.69 | -120.7 | -406.4 | 458.7 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -17989.06 | -17989.1 | 531.4 | 22915.1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 88513.13 | 15908.9 | 33897.9 | 33366.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 106502.18 | 33897.9 | 33366.5 | 10451.3 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 87157.24 | 87157.2 | 56764.4 | 18124 | |||||||||||||||||
cash-flows.row.capital-expenditure | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.free-cash-flow | 48595.33 | 44190 | 44411.9 | 5222.4 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 748526.71 | 748526.7 | 684351.1 | 606584.9 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 412984.31 | 412854.3 | 396396.6 | 372208.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 335542.4 | 335672.4 | 287954.5 | 234376.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 33671.36 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 204703.62 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.operating-expenses | -2317.17 | 238911.4 | 225175.5 | 203176.5 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 474255.45 | 651765.7 | 621572 | 575385.1 | |||||||||||||||||
income-statement-row.row.interest-income | 5893.15 | 5893.1 | 5321.5 | 1654.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 179363.79 | 22444.6 | 19571.5 | 16180.7 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 279325.21 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 99961.42 | 96761 | 62960.9 | 31199.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 54310.64 | 54215.4 | 45362 | 20532.7 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 16406.19 | 16406.2 | 15509.4 | 21974.1 | |||||||||||||||||
income-statement-row.row.net-income | 37006.33 | 37006.3 | 31891.7 | -1441.5 |
Questions fréquemment posées
Quel est le total de JW Pharmaceutical Corporation (001060.KS) de l'actif total?
JW Pharmaceutical Corporation (001060.KS) Le total des actifs est 645038796101.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 389220837356.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.448.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 2124.292.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.049.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.134.
Qu'est-ce que JW Pharmaceutical Corporation (001060.KS) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 37006333990.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 170280439662.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 238911370958.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 15908868301.000.